Frontline Therapy and MRD: Exciting New Data from France

Submitted by Dr. Brian GM Durie on Thu, 07/31/2014 - 00:00

A recent study illustrates just how useful minimal residual disease (MRD) testing by flow cytometry is to predict excellent outcomes with new highly active combination therapies.